PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1419157
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1419157
The Asia-Pacific electronic Clinical Outcome Assessment (eCOA) market is expected to reach USD 997,422.90 thousand by 2031 from USD 288,608.85 thousand in 2023, growing at a CAGR of 16.8% during the forecast period of 2024 to 2031.
Asia-Pacific Electronic Clinical Outcome Assessment (eCOA) Market, By Type (Clinician Reported Outcome Assessment (CLINRO), Patient Reported Outcome Assessment (PRO), Observer Reported Outcome Assessment (OBSRO), and Performance Outcome Assessment (PERFO)), Modality (Site-Based Solutions, Web Solutions, and Handheld), End User (Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Firms, Medical Device Companies, Hospitals/Healthcare Providers, Consulting Service Companies, Academic & Research Institutes, and Others), Delivery Mode (Cloud-Based and Web-Hosted), Country (China, Japan, Australia, South Korea, India, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific) - Industry Trends and Forecast to 2031.